Mostrar el registro sencillo

dc.contributor.authorPrieto Peña, Diana es_ES
dc.contributor.authorRemuzgo Martínez, Saraes_ES
dc.contributor.authorGenre, Fernandaes_ES
dc.contributor.authorPulito Cueto, Verónicaes_ES
dc.contributor.authorAtienza Mateo, Belén  es_ES
dc.contributor.authorLlorca Díaz, Francisco Javier es_ES
dc.contributor.authorSevilla-Pérez, Belénes_ES
dc.contributor.authorOrtego-Centeno, Norbertoes_ES
dc.contributor.authorMarquez, Anaes_ES
dc.contributor.authorLera-Gómez, Leticiaes_ES
dc.contributor.authorLeonardo, María Teresaes_ES
dc.contributor.authorPeñalba, Anaes_ES
dc.contributor.authorNarváez, Javieres_ES
dc.contributor.authorMartín Penagos, Luises_ES
dc.contributor.authorRodrigo Calabia, Emilio es_ES
dc.contributor.authorMiranda-Filloy, José Aes_ES
dc.contributor.authorCaminal-Montero, Luises_ES
dc.contributor.authorBlanco Alonso, Ricardo es_ES
dc.contributor.authorGonzález-Gay Mantecón, Miguel Ángel es_ES
dc.contributor.authorLópez Mejías, Raqueles_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2022-02-23T16:15:49Z
dc.date.available2022-02-23T16:15:49Z
dc.date.issued2021es_ES
dc.identifier.issn2045-2322es_ES
dc.identifier.urihttp://hdl.handle.net/10902/24045
dc.description.abstractCytokines signalling pathway genes are crucial factors of the genetic network underlying the pathogenesis of Immunoglobulin-A vasculitis (IgAV), an inflammatory vascular condition. An influence of the interleukin (IL)33- IL1 receptor like (IL1RL)1 signalling pathway on the increased risk of several immune-mediated diseases has been described. Accordingly, we assessed whether the IL33-IL1RL1 pathway represents a novel genetic risk factor for IgAV. Three tag polymorphisms within IL33 (rs3939286, rs7025417 and rs7044343) and three within IL1RL1 (rs2310173, rs13015714 and rs2058660), that also were previously associated with several inflammatory diseases, were genotyped in 380 Caucasian IgAV patients and 845 matched healthy controls. No genotypes or alleles differences were observed between IgAV patients and controls when IL33 and IL1RL1 variants were analysed independently. Likewise, no statistically significant differences were found in IL33 or IL1RL1 genotype and allele frequencies when IgAV patients were stratified according to the age at disease onset or to the presence/absence of gastrointestinal (GI) or renal manifestations. Similar results were disclosed when IL33 and IL1RL1 haplotypes were compared between IgAV patients and controls and between IgAV patients stratified according to the clinical characteristics mentioned above. Our results suggest that the IL33-IL1RL1 signalling pathway does not contribute to the genetic network underlying IgAV.es_ES
dc.description.sponsorshipAcknowledgements: We are indebted to the patients and healthy controls for their essential collaboration to this study. We also thank the National DNA Bank Repository (Salamanca) for supplying part of the control samples. This study was supported by European Union FEDER funds and `Fondo de Investigaciones Sanitarias´ (Grant PI18/00042) from ‘Instituto de Salud Carlos III’ (ISCIII, Health Ministry, Spain). DP-P is a recipient of a Río Hortega programme fellowship from the ISCIII, co-funded by the European Social Fund (ESF, `Investing in your future´) (Grant Number CM20/00006). SR-M is supported by funds of the RETICS Program (RD16/0012/0009) (ISCIII, cofunded by the European Regional Development Fund (ERDF)). VP-C is supported by a pre-doctoral grant from IDIVAL (PREVAL 18/01). BA-M is a recipient of a `López Albo´ Post-Residency Programme funded by Servicio Cántabro de Salud. LL-G is supported by funds from IDIVAL (INNVAL20/06). OG is staff personnel of Xunta de Galicia (Servizo Galego de Saude (SERGAS)) through a research-staff stabilization contract (ISCIII/SERGAS) and his work is funded by ISCIII and the European Union FEDER fund (Grant Numbers RD16/0012/0014 (RIER) and PI17/00409). He is beneficiary of project funds from the Research Executive Agency (REA) of the European Union in the framework of MSCA-RISE Action of the H2020 Programme, project 734899—Olive-Net. RL-M is a recipient of a Miguel Servet type I programme fellowship from the ISCIII, co-funded by ESF (`Investing in your future´) (Grant Number CP16/00033).es_ES
dc.format.extent8 p.es_ES
dc.language.isoenges_ES
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceSci Rep . 2021 Aug 9;11(1):16163es_ES
dc.titleRole of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1038/s41598-021-95762-5es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1038/s41598-021-95762-5es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International